Accordingly, gemcitabine and 5-fluorouracil exert increased antitumor effects when tumors were established in NLRP3−/− or Caspase-1−/− mice, and NLRP3 activation by chemotherapeutic drugs is considered to be a positive regulator to promote cancer growth [101]. This evidence concerns the gene NLRP3 and cancer.